Neuroblastic Tumors with Expression of Disialoglycosphingolipids GD2 and/or GD3

被引：0
|
作者：
Nishimaki, Haruna [1 ]
Nakanishi, Yoko [2 ]
Masuda, Shinobu
机构：
[1] Nihon Univ, Sch Med, Itabashi Ku, Tokyo, Japan
[2] Nihon Univ, Sch Med, Oyaguchi Kami Cho, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1862
引用
收藏
页码：1741 / 1742
页数：2
相关论文
共 50 条
  • [1] Neuroblastic Tumors with Expression of Disialoglycosphingolipids GD2 and/or GD3
    Nishimaki, Haruna
    Nakanishi, Yoko
    Masuda, Shinobu
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1741 - 1742
  • [2] Different co-expression patterns of GD2 and GD3 in pediatric neuroblastic tumors
    Nishimaki, Haruna
    Nakanishi, Yoko
    Kobayashi, Hiroko
    Chin, Motoaki
    Masuda, Shinobu
    CANCER SCIENCE, 2018, 109 : 1138 - 1138
  • [3] GD2 expression and clinicopathological characteristics in neuroblastic tumors
    Nishimaki, Haruna
    Noda, Hiroko
    Chin, Motoaki
    Masuda, Shinobu
    CANCER SCIENCE, 2018, 109 : 346 - 346
  • [4] Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
    Yanagisawa, Makoto
    Yoshimura, Saori
    Yu, Robert K.
    ASN NEURO, 2011, 3 (02): : 69 - 74
  • [5] EXPRESSION OF THE GANGLIOSIDES GD3 AND GD2 ON LYMPHOCYTES IN TISSUE-SECTIONS OF MELANOMA
    HERSEY, P
    JAMAL, O
    PATHOLOGY, 1989, 21 (01) : 51 - 58
  • [6] EXPRESSION OF DISIALOGANGLIOSIDES GD2 AND GD3 ON HUMAN SOFT-TISSUE SARCOMAS
    CHANG, HR
    CORDONCARDO, C
    HOUGHTON, AN
    CHEUNG, NKV
    BRENNAN, MF
    CANCER, 1992, 70 (03) : 633 - 638
  • [7] Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy
    Terzic, Tatjana
    Cordeau, Martine
    Herblot, Sabine
    Teira, Pierre
    Cournoyer, Sonia
    Beaunoyer, Mona
    Peuchmaur, Michel
    Duval, Michel
    Sartelet, Herve
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2018, 21 (04) : 355 - 362
  • [8] Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma
    Murphy, Jacqueline D.
    Axiak-Bechtel, Sandra
    Milner, Rowan J.
    Lejeune, Amandine
    Ossiboff, Robert J.
    Gell, Jessy Castellanos
    Shiomitsu, Keijiro
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2023, 259
  • [9] GD2/GD3 expression: Companion diagnostic for ganglioside-targeted immunotherapy against pediatric solid tumors.
    Dobrenkov, Konstantin
    Ostrovnaya, Irina
    Cheung, Irene Y.
    Feng, Yi
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] GD2 and GD3 synthase: novel drug targets for cancer therapy
    Sphyris, Nathalie
    Sarkar, Tapasree Roy
    Battula, Venkata L.
    Andreeff, Michael
    Mani, Sendurai A.
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (03):
12345